ANIP Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-03-23 | Marken James G. | officer: SVP OPS & PROD DEV | 112,730 | F-InKind | D | 2,452 | 37.82 | 92,734.64 |
| 2023-03-23 | CAREY STEPHEN P. | officer: SVP AND CFO | 138,906 | F-InKind | D | 4,224 | 37.82 | 159,751.68 |
| 2023-03-23 | Lalwani Nikhil | director, officer: PRESIDENT & CEO | 250,840 | F-InKind | D | 17,455 | 37.82 | 660,148.10 |
| 2023-03-07 | Lalwani Nikhil | director, officer: PRESIDENT & CEO | 268,295 | F-InKind | D | 4,265 | 44.23 | 188,640.95 |
| 2023-03-07 | Lalwani Nikhil | director, officer: PRESIDENT & CEO | 272,560 | F-InKind | D | 9,397 | 44.23 | 415,629.31 |
| 2023-03-07 | CAREY STEPHEN P. | officer: SVP AND CFO | 143,130 | F-InKind | D | 864 | 44.23 | 38,214.72 |
| 2023-03-07 | CAREY STEPHEN P. | officer: SVP AND CFO | 143,994 | F-InKind | D | 2,639 | 44.23 | 116,722.97 |
| 2023-03-07 | Gutwerg Ori | officer: SVP, GENERICS | 34,027 | F-InKind | D | 586 | 44.23 | 25,918.78 |
| 2023-03-07 | Gutwerg Ori | officer: SVP, GENERICS | 34,613 | F-InKind | D | 1,756 | 44.23 | 77,667.88 |
| 2023-03-07 | Mutz Christopher | officer: HEAD OF RARE DISEASE | 37,660 | F-InKind | D | 476 | 44.23 | 21,053.48 |
| 2023-03-07 | Mutz Christopher | officer: HEAD OF RARE DISEASE | 38,136 | F-InKind | D | 1,426 | 44.23 | 63,071.98 |
| 2023-03-07 | Marken James G. | officer: SVP OPS & PROD DEV | 115,182 | F-InKind | D | 509 | 44.23 | 22,513.07 |
| 2023-03-07 | Marken James G. | officer: SVP OPS & PROD DEV | 115,691 | F-InKind | D | 1,951 | 44.23 | 86,292.73 |
| 2023-02-15 | Gutwerg Ori | officer: SVP, GENERICS | 36,369 | F-InKind | D | 1,275 | 45.04 | 57,426.00 |
| 2023-02-15 | Mutz Christopher | officer: HEAD OF RARE DISEASE | 39,562 | F-InKind | D | 1,292 | 45.04 | 58,191.68 |
| 2022-12-01 | MERIDIAN VENTURE PARTNERS II LP | 10 percent owner | 2,019,259 | S-Sale | D | 200,000 | 38.50 | 7,700,000.00 |
| 2022-09-12 | Davis Krista | officer: SVP, CHIEF HR OFFICER | 16,433 | A-Award | A | 16,433 | 0.00 | 0.00 |
| 2022-09-08 | Lalwani Nikhil | director, officer: PRESIDENT & CEO | 281,957 | F-InKind | D | 3,646 | 37.61 | 137,126.06 |
| 2022-08-15 | Marken James G. | officer: SVP OPS & PROD DEV | 117,642 | S-Sale | D | 5,172 | 37.79 | 195,463.84 |
| 2022-08-12 | Marken James G. | officer: SVP OPS & PROD DEV | 122,814 | S-Sale | D | 12,894 | 37.04 | 477,605.36 |
| 2022-07-18 | Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 19,280 | A-Award | A | 19,280 | 0.00 | 0.00 |
| 2022-04-27 | Gutwerg Ori | officer: SVP, GENERICS | 37,644 | A-Award | A | 6,476 | 0.00 | 0.00 |
| 2022-04-27 | Mutz Christopher | officer: HEAD OF RARE DISEASE | 40,854 | A-Award | A | 6,476 | 0.00 | 0.00 |
| 2022-04-27 | Marken James G. | officer: SVP OPS & PROD DEV | 135,708 | A-Award | A | 6,644 | 0.00 | 0.00 |
| 2022-04-27 | HAUGHEY THOMAS | director | 40,251 | A-Award | A | 10,049 | 0.00 | 0.00 |
| 2022-04-27 | Lalwani Nikhil | director, officer: PRESIDENT & CEO | 285,603 | A-Award | A | 33,352 | 0.00 | 0.00 |
| 2022-04-27 | CAREY STEPHEN P. | officer: SENIOR VICE PRESIDENT AND CFO | 146,633 | A-Award | A | 11,291 | 0.00 | 0.00 |
| 2022-04-27 | Pera Antonio R | director | 29,762 | A-Award | A | 10,049 | 0.00 | 0.00 |
| 2022-04-27 | NASH DAVID | director | 31,696 | A-Award | A | 10,049 | 0.00 | 0.00 |
| 2022-04-27 | Brown Robert E. JR | director | 49,021 | A-Award | A | 10,049 | 0.00 | 0.00 |
| 2022-04-27 | Walsh Patrick D | director | 63,437 | A-Award | A | 10,049 | 0.00 | 0.00 |
| 2022-04-27 | Thoma Jeanne | director | 29,334 | A-Award | A | 10,049 | 0.00 | 0.00 |
| 2022-04-10 | CAREY STEPHEN P. | officer: SENIOR VICE PRESIDENT AND CFO | 135,342 | F-InKind | D | 4,534 | 29.91 | 135,611.94 |
| 2022-04-10 | Marken James G. | officer: SVP OPS & PROD DEV | 129,064 | F-InKind | D | 1,878 | 29.91 | 56,170.98 |
| 2022-04-06 | CAREY STEPHEN P. | officer: SENIOR VICE PRESIDENT AND CFO | 139,876 | F-InKind | D | 912 | 29.69 | 27,077.28 |
| 2022-04-06 | Marken James G. | officer: SVP OPS & PROD DEV | 130,942 | F-InKind | D | 337 | 29.69 | 10,005.53 |
| 2022-03-28 | CAREY STEPHEN P. | officer: SENIOR VICE PRESIDENT AND CFO | 140,788 | F-InKind | D | 1,420 | 28.17 | 40,001.40 |
| 2022-03-28 | Marken James G. | officer: SVP OPS & PROD DEV | 131,279 | F-InKind | D | 524 | 28.17 | 14,761.08 |
| 2022-03-24 | Mutz Christopher | officer: HEAD OF RARE DISEASE | 34,378 | A-Award | A | 19,428 | 0.00 | 0.00 |
| 2022-03-24 | Gutwerg Ori | officer: SVP, GENERICS | 31,168 | A-Award | A | 19,428 | 0.00 | 0.00 |
| 2022-03-24 | Marken James G. | officer: SVP OPS & PROD DEV | 131,803 | A-Award | A | 19,934 | 0.00 | 0.00 |
| 2022-03-24 | Lalwani Nikhil | director, officer: PRESIDENT & CEO | 252,251 | A-Award | A | 100,055 | 0.00 | 0.00 |
| 2022-03-24 | CAREY STEPHEN P. | officer: SENIOR VICE PRESIDENT AND CFO | 142,208 | A-Award | A | 33,875 | 0.00 | 0.00 |
| 2022-03-23 | Marken James G. | officer: SVP OPS & PROD DEV | 111,869 | F-InKind | D | 2,452 | 27.03 | 66,277.56 |
| 2022-03-23 | Lalwani Nikhil | director, officer: PRESIDENT & CEO | 152,196 | F-InKind | D | 17,454 | 27.03 | 471,781.62 |
| 2022-03-23 | CAREY STEPHEN P. | officer: SENIOR VICE PRESIDENT AND CFO | 108,333 | F-InKind | D | 4,167 | 27.03 | 112,634.01 |
| 2022-03-21 | Lalwani Nikhil | director, officer: PRESIDENT & CEO | 169,650 | P-Purchase | A | 7,224 | 27.69 | 199,997.16 |
| 2022-03-21 | Walsh Patrick D | director | 53,388 | P-Purchase | A | 5,000 | 27.76 | 138,794.00 |
| 2022-03-21 | Gassert Chad | officer: SVP - CORP. DEV. & STRATEGY | 393,226 | P-Purchase | A | 5,000 | 27.87 | 139,342.50 |
| 2022-03-19 | TANNENBAUM RENEE P | director | 13,346 | A-Award | A | 13,346 | 0.00 | 0.00 |
| 2022-03-18 | Gassert Chad | officer: SVP - CORP. DEV. & STRATEGY | 388,226 | P-Purchase | A | 5,000 | 27.15 | 135,744.00 |
| 2022-03-17 | Shanmugam Muthusamy | director, officer: HEAD OF R&D, COO-NOVITIUM OPS | 5,000 | P-Purchase | A | 5,000 | 27.65 | 138,251.50 |
| 2022-03-17 | Shanmugam Muthusamy | director, officer: HEAD OF R&D, COO-NOVITIUM OPS | 18,460 | P-Purchase | A | 5,000 | 27.65 | 138,251.50 |
| 2022-02-15 | Gutwerg Ori | officer: SVP, GENERICS | 11,740 | F-InKind | D | 1,167 | 40.25 | 46,971.75 |
| 2022-02-15 | Mutz Christopher | officer: HEAD OF RARE DISEASE | 14,950 | F-InKind | D | 1,184 | 40.25 | 47,656.00 |
| 2021-12-20 | Thoma Jeanne | director | 17,785 | P-Purchase | A | 1,072 | 46.47 | 49,819.59 |
| 2021-12-07 | Pera Antonio R | director | 19,713 | P-Purchase | A | 3,000 | 42.26 | 126,793.50 |
| 2021-12-06 | HAUGHEY THOMAS | director | 30,202 | P-Purchase | A | 2,500 | 39.38 | 98,450.00 |
| 2021-11-19 | Gassert Chad | officer: SVP - CORP. DEV. & STRATEGY | 383,226 | A-Award | A | 383,226 | 0.00 | 0.00 |
| 2021-11-19 | Shanmugam Muthusamy | director, officer: HEAD OF R&D, COO-NOVITIUM OPS | 1,332,620 | A-Award | A | 1,332,620 | 0.00 | 0.00 |
| 2021-11-19 | Shanmugam Muthusamy | director, officer: HEAD OF R&D, COO-NOVITIUM OPS | 13,460 | A-Award | A | 13,460 | 0.00 | 0.00 |
| 2021-09-08 | Lalwani Nikhil | PRESIDENT & CEO | 162,426 | F-InKind | D | 2,577 | 28.20 | 72,671.40 |
| 2021-04-12 | CAREY STEPHEN P. | SENIOR VICE PRESIDENT AND CFO | 112,500 | F-InKind | D | 3,042 | 31.86 | 96,918.12 |
| 2021-04-12 | Marken James G. | SVP OPS & PROD DEV | 114,321 | F-InKind | D | 1,878 | 31.86 | 59,833.08 |
| 2021-04-06 | Marken James G. | officer: SVP Ops & Prod Dev | 116,199 | F-InKind | D | 337 | 33.69 | 11,353.53 |
| 2021-04-06 | CAREY STEPHEN P. | officer: Vice President and CFO | 115,542 | F-InKind | D | 612 | 33.69 | 20,618.28 |
| 2021-03-31 | CAREY STEPHEN P. | officer: Vice President and CFO | 116,154 | F-InKind | D | 508 | 36.14 | 18,359.12 |
| 2021-03-31 | Marken James G. | officer: SVP Ops & Prod Dev | 116,536 | F-InKind | D | 278 | 36.14 | 10,046.92 |
| 2021-03-29 | Schrepfer Robert W | officer: SVP - New Bus Dev & Spec Sales | 87,477 | F-InKind | D | 5,566 | 32.68 | 181,896.88 |
| 2021-03-29 | CAREY STEPHEN P. | officer: Vice President and CFO | 116,662 | F-InKind | D | 953 | 32.68 | 31,144.04 |
| 2021-03-29 | Marken James G. | officer: SVP Ops & Prod Dev | 116,814 | F-InKind | D | 524 | 32.68 | 17,124.32 |
| 2021-03-23 | NASH DAVID | director | 21,647 | A-Award | A | 9,292 | 0.00 | 0.00 |
| 2021-03-23 | Thoma Jeanne | director | 16,713 | A-Award | A | 9,292 | 0.00 | 0.00 |
| 2021-03-23 | HAUGHEY THOMAS | director | 27,702 | A-Award | A | 9,292 | 0.00 | 0.00 |
| 2021-03-23 | Pera Antonio R | director | 16,713 | A-Award | A | 9,292 | 0.00 | 0.00 |
| 2021-03-23 | Brown Robert E. JR | director | 38,972 | A-Award | A | 9,292 | 0.00 | 0.00 |
| 2021-03-23 | Marken James G. | officer: SVP Ops & Prod Dev | 117,338 | A-Award | A | 32,041 | 0.00 | 0.00 |
| 2021-03-23 | Walsh Patrick D | director | 48,388 | A-Award | A | 9,292 | 0.00 | 0.00 |
| 2021-03-23 | Lalwani Nikhil | director, officer: PRESIDENT & CEO | 165,003 | A-Award | A | 136,495 | 0.00 | 0.00 |
| 2021-03-23 | CAREY STEPHEN P. | officer: Vice President and CFO | 117,615 | A-Award | A | 54,470 | 0.00 | 0.00 |
| 2021-03-16 | Thoma Jeanne | director | 19,285 | P-Purchase | A | 1,500 | 33.22 | 49,830.00 |
| 2021-03-15 | Walsh Patrick D | director | 39,096 | P-Purchase | A | 4,000 | 32.89 | 131,555.20 |
| 2021-02-15 | Mutz Christopher | CHIEF COMMERCIAL OFFICER | 16,134 | A-Award | A | 16,134 | 0.00 | 0.00 |
| 2021-02-15 | Mutz Christopher | CHIEF COMMERCIAL OFFICER | 33,758 | A-Award | A | 33,758 | 31.49 | 1,063,039.42 |
| 2021-02-15 | Gutwerg Ori | SVP, GENERICS | 12,907 | A-Award | A | 12,907 | 0.00 | 0.00 |
| 2021-02-15 | Gutwerg Ori | SVP, GENERICS | 27,006 | A-Award | A | 27,006 | 31.49 | 850,418.94 |
| 2020-11-09 | Walsh Patrick D | director | 35,096 | P-Purchase | A | 5,000 | 25.96 | 129,800.00 |
| 2020-09-08 | Lalwani Nikhil | director, officer: PRESIDENT & CEO | 28,508 | A-Award | A | 28,508 | 0.00 | 0.00 |
| 2020-09-08 | Lalwani Nikhil | director, officer: PRESIDENT & CEO | 179,643 | A-Award | A | 179,643 | 29.00 | 5,209,647.00 |
| 2020-08-10 | Walsh Patrick D | director | 27,096 | P-Purchase | A | 4,000 | 30.98 | 123,920.00 |
| 2020-08-10 | Walsh Patrick D | director | 23,096 | P-Purchase | A | 3,000 | 30.89 | 92,670.00 |
| 2020-08-10 | Walsh Patrick D | director | 30,096 | P-Purchase | A | 3,000 | 30.89 | 92,670.00 |
| 2020-08-05 | Thoma Jeanne | director | 7,421 | A-Award | A | 7,421 | 0.00 | 0.00 |
| 2020-08-05 | Pera Antonio R | director | 16,024 | A-Award | A | 16,024 | 0.00 | 0.00 |
| 2020-08-05 | Pera Antonio R | director | 7,421 | A-Award | A | 7,421 | 0.00 | 0.00 |
| 2020-08-05 | Thoma Jeanne | director | 16,024 | A-Award | A | 16,024 | 0.00 | 0.00 |
| 2020-05-11 | Walsh Patrick D | director | 20,096 | A-Award | A | 7,050 | 0.00 | 0.00 |
| 2020-04-10 | Marken James G. | officer: SVP Ops & Prod Dev | 85,297 | A-Award | A | 24,548 | 0.00 | 0.00 |
| 2020-04-10 | Schrepfer Robert W | officer: SVP - New Bus Dev & Spec Sales | 93,043 | A-Award | A | 39,767 | 0.00 | 0.00 |
| 2020-04-10 | CAREY STEPHEN P. | officer: Vice President and CFO | 63,145 | A-Award | A | 39,767 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.